These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 8697997

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Prognostic significance of CEA levels and detection of CEA mRNA in draining venous blood in patients with colorectal cancer.
    Kanellos I, Zacharakis E, Kanellos D, Pramateftakis MG, Tsahalis T, Altsitsiadis E, Betsis D.
    J Surg Oncol; 2006 Jul 01; 94(1):3-8. PubMed ID: 16788936
    [Abstract] [Full Text] [Related]

  • 23. Clinical value of determination of urokinase-type plasminogen activator antigen in plasma for detection of colorectal cancer: comparison with circulating tumor-associated antigens CA 19-9 and carcinoembryonic antigen.
    Huber K, Kirchheimer JC, Sedlmayer A, Bell C, Ermler D, Binder BR.
    Cancer Res; 1993 Apr 15; 53(8):1788-93. PubMed ID: 8467497
    [Abstract] [Full Text] [Related]

  • 24. [Evaluation of combined CA-19-9 and CEA assay in monitoring recurrences and metastases of colorectal cancer].
    Yu BM.
    Zhonghua Wai Ke Za Zhi; 1992 Dec 15; 30(12):707-9, 777. PubMed ID: 1339738
    [Abstract] [Full Text] [Related]

  • 25. Comparative analysis of CA 242 and CA 19-9 serum tumor markers in colorectal cancer patients. A longitudinal evaluation.
    Spila A, Ferroni P, Cosimelli M, D'Alessandro R, Abbolito MR, Mariotti S, Aloe S, Carone MD, Graziano F, Tedesco M, Martini F, Mancini R, Stigliano V, Roselli M, Guadagni F.
    Anticancer Res; 2001 Dec 15; 21(2B):1263-70. PubMed ID: 11396197
    [Abstract] [Full Text] [Related]

  • 26. Serum CA 242 and CEA detect different patients with recurrent colorectal cancer.
    Carpelan-Holmström MA, Haglund CH, Järvinen HJ, Roberts PJ.
    Anticancer Res; 1996 Dec 15; 16(2):981-6. PubMed ID: 8687164
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Value of plasma alpha-1-acid glycoprotein assay in the detection of human colorectal cancer: comparison with carcinoembryonic antigen.
    Chu CY, Lai LT, Pokala HP.
    J Natl Cancer Inst; 1982 Jan 15; 68(1):75-9. PubMed ID: 7033631
    [Abstract] [Full Text] [Related]

  • 29. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R, Kiefe C, Rose E, Sutton F, Brown J, Alpert E.
    Cancer Res; 1993 Jun 15; 53(12):2803-9. PubMed ID: 7684947
    [Abstract] [Full Text] [Related]

  • 30. [Significance of combined determination of CK19mRNA, carcinoembryanic antigen, neuron-specific enolase, and tissue polypeptide antigen in peripheral blood of patients with lung cancer].
    Pan QR, Zhang X, Xu ZF, Zheng S.
    Ai Zheng; 2002 Feb 15; 21(2):196-9. PubMed ID: 12479076
    [Abstract] [Full Text] [Related]

  • 31. Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.
    Chen Y, Gao SG, Chen JM, Wang GP, Wang ZF, Zhou B, Jin CH, Yang YT, Feng XS.
    Cell Biochem Biophys; 2015 Apr 15; 71(3):1287-91. PubMed ID: 25486903
    [Abstract] [Full Text] [Related]

  • 32. [Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].
    Grotowski M, Maruszyński M, Piechota W.
    Pol Merkur Lekarski; 2001 Dec 15; 11(66):476-9. PubMed ID: 11899841
    [Abstract] [Full Text] [Related]

  • 33. Prognostic value of preoperative CEA, CA 19-9, CA 72-4, and AFP levels in gastric cancer.
    Ucar E, Semerci E, Ustun H, Yetim T, Huzmeli C, Gullu M.
    Adv Ther; 2008 Oct 15; 25(10):1075-84. PubMed ID: 18821070
    [Abstract] [Full Text] [Related]

  • 34. [Expression of tumor-associated antigen LEA and its significance for pathological diagnosis].
    Feng H, Song JD.
    Ai Zheng; 2002 Jun 15; 21(6):658-62. PubMed ID: 12452070
    [Abstract] [Full Text] [Related]

  • 35. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
    Jiang XT, Tao HQ, Zou SC.
    Hepatobiliary Pancreat Dis Int; 2004 Aug 15; 3(3):464-8. PubMed ID: 15313690
    [Abstract] [Full Text] [Related]

  • 36. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
    Huang C, Bei L, Liu T.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug 15; 20(4):285-8. PubMed ID: 11367693
    [Abstract] [Full Text] [Related]

  • 37. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W, Stieber P, Reuter C, Nagel D, Lau-Werner U, Lamerz R.
    Anticancer Res; 2000 Aug 15; 20(6D):5195-8. PubMed ID: 11326694
    [Abstract] [Full Text] [Related]

  • 38. [Clinical value of serum CEA, CA19-9, CA72-4 and CA242 in the diagnosis and prognosis of gastric cancer].
    Zhu YB, Ge SH, Zhang LH, Wang XH, Xing XF, DU H, Hu Y, Li YA, Jia YN, Lin Y, Fan B, Ji JF.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Feb 15; 15(2):161-4. PubMed ID: 22368025
    [Abstract] [Full Text] [Related]

  • 39. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
    Yang XQ, Yan L, Chen C, Hou JX, Li Y.
    Hepatogastroenterology; 2009 Feb 15; 56(94-95):1388-94. PubMed ID: 19950797
    [Abstract] [Full Text] [Related]

  • 40. Use of the preoperative levels of CEA in patients with colorectal cancer.
    Marchena J, Acosta MA, Garcia-Anguiano F, Simpson H, Cruz F.
    Hepatogastroenterology; 2003 Feb 15; 50(52):1017-20. PubMed ID: 12845969
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.